Frederick S Vizeacoumar

11PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologySemi- and unsupervised learningProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent response.

|Apr 29, 2025
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Prachi Walke, Jared D W Price, Frederick S Vizeacoumar

|Apr 25, 2025
Metabolic Effects of the Cancer Metastasis Modulator MEMO1.

Marziyeh Ghanbarian, Natalia Dolgova, Frederick S Vizeacoumar

|Jan 08, 2025
Cancer Cell's Achilles Heels: Considerations for Design of Anti-Cancer Drug Combinations.

Valid Gahramanov, Frederick S Vizeacoumar, Alain Morejon Morales

|Oct 15, 2024
Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model.

Yulian Ding, Connor Denomy, Andrew Freywald

|Mar 28, 2023
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

Amr El Zawily, Frederick S Vizeacoumar, Renuka Dahiya

Pageof 2

Frequent Collaborators

8 joint publications

Franco J Vizeacoumar

2 joint publications

Anand Krishnan

1 joint publications

Shawn C Chafe

1 joint publications

Geetha Venkateswaran